RT Journal Article
T1 Fruit and Vegetable Consumption is Inversely Associated with Plasma Saturated Fatty Acids at Baseline in Predimed Plus Trial.
A1 Dominguez-Lopez, Ines
A1 Marhuenda-Muñoz, Maria
A1 Tresserra-Rimbau, Anna
A1 Hernaez, Alvaro
A1 Moreno, Juan Jose
A1 Martinez-Gonzalez, Miguel Angel
A1 Salas-Salvado, Jordi
A1 Corella, Dolores
A1 Fito, Montserrat
A1 Martinez, Jose Alfredo
A1 Alonso-Gomez, Angel M
A1 Wärnberg, Julia
A1 Vioque, Jesus
A1 Romaguera, Dora
A1 Lopez-Miranda, Jose
A1 Bernal-Lopez, M Rosa
A1 Lapetra, Jose
A1 Serra-Majem, J Luis
A1 Bueno-Cavanillas, Aurora
A1 Tur, Josep A
A1 Martin-Sanchez, Vicente
A1 Pinto, Xavier
A1 Delgado-Rodriguez, Miguel
A1 Matia-Martin, Pilar
A1 Vidal, Josep
A1 Vazquez, Clotilde
A1 Daimiel, Lidia
A1 Serra-Mir, Merce
A1 Vazquez-Ruiz, Zenaida
A1 Nishi, Stephanie K
A1 Sorli, Jose V
A1 Castañer, Olga
A1 Abete, Itziar
A1 Luna, Jessica Vaquero
A1 Carabaño-Moral, Rosa
A1 Asencio, Alberto
A1 Prohens, Lara
A1 Garcia-Rios, Antonio
A1 Casas, Rosa
A1 Gomez-Perez, Ana Maria
A1 Santos-Lozano, Jose Manuel
A1 Razquin, Cristina
A1 Martinez, Maria Angeles
A1 Saiz, Carmen
A1 Robledo-Pastor, Vanesa
A1 Zulet, Maria Angeles
A1 Salaverria, Itziar
A1 Eguaras, Sonia
A1 Babio, Nancy
A1 Malcampo, Mireia
A1 Ros, Emilio
A1 Estruch, Ramon
A1 Lopez-Sabater, M Carmen
A1 Lamuela-Raventos, Rosa M
K1 MUFA
K1 PREDIMED-Plus
K1 PUFA
K1 Dietary fats, Mediterranean diet
AB Plasma fatty acids (FAs) are associated with the development of cardiovascular diseases and metabolic syndrome. The aim of our study is to assess the relationship between fruit and vegetable (F&V) consumption and plasma FAs and their subtypes. Plasma FAs are assessed in a cross-sectional analysis of a subsample of 240 subjects from the PREDIMED-Plus study. Participants are categorized into four groups of fruit, vegetable, and fat intake according to the food frequency questionnaire. Plasma FA analysis is performed using gas chromatography. Associations between FAs and F&V consumption are adjusted for age, sex, physical activity, body mass index (BMI), total energy intake, and alcohol consumption. Plasma saturated FAs are lower in groups with high F&V consumption (-1.20 mg cL-1 [95% CI: [-2.22, -0.18], p-value = 0.021), especially when fat intake is high (-1.74 mg cL-1 [95% CI: [-3.41, -0.06], p-value = 0.042). Total FAs and n-6 polyunsaturated FAs tend to be lower in high consumers of F&V only in the high-fat intake groups. F&V consumption is associated with lower plasma saturated FAs when fat intake is high. These findings suggest that F&V consumption may have different associations with plasma FAs depending on their subtype and on the extent of fat intake.
PB Wiley
YR 2021
FD 2021-07-28
LK http://hdl.handle.net/10668/18209
UL http://hdl.handle.net/10668/18209
LA en
NO Domínguez-López I, Marhuenda-Muñoz M, Tresserra-Rimbau A, Hernáez Á, Moreno JJ, Martínez-González MÁ, et al. Fruit and Vegetable Consumption is Inversely Associated with Plasma Saturated Fatty Acids at Baseline in Predimed Plus Trial. Mol Nutr Food Res. 2021 Sep;65(17):e2100363
NO I.D.-L. is supported by the [FI_B 00256] from the FI-AGAUR Research Fel lowship Program, Generalitat de Catalunya and M.M.-M is supported bythe FPU17/00513 grant. Á.-H. is supported by the [CD17/00122] grant andS.K.N. is supported by a Canadian Institutes of Health Research (CIHR)Fellowship. We also thank all the volunteers for their participation in andthe personnel for their contribution to the PREDIMED-Plus trial. This re search was funded by CiCYT [AGL2016-75329-R] and CIBEROBN fromthe Instituto de Salud Carlos III, ISCIII from the Ministerio de Ciencia,Innovación y Universidades, (AEI/FEDER, UE), Generalitat de Catalunya(GC) [2017SGR196]. The PREDIMED-Plus trial was supported by the offi cial Spanish Institutions for funding scientific biomedical research, CIBERFisiopatología de la Obesidad y Nutrición (CIBERobn) and Instituto deSalud Carlos III (ISCIII), through the Fondo de Investigación para la Salud(FIS), which is co-funded by the European Regional Development Fund(four coordinated Fondo de Investigaciones Sanitarias projects lead byJ.S.-S. and J.V., including the following projects: PI13/00673, PI13/00492,PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618,PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873,PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347,PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926 and PI19/00781), the Especial ActionProject entitled Implementación y evaluación de una intervención inten siva sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S., Eu ropean Research Council (Advanced Research Grant 2014–2019, 340918)to M.Á.M.-G., the Recercaixa grant to J.S.-S. (2013ACUP00194), grantsfrom the Consejería de Salud de la Junta de Andalucía (PI0458/2013,PS0358/2016, and PI0137/2018), a grant from the Generalitat Valenciana(PROMETEO/2017/017), a SEMERGEN grant, Fundació la Marató deTV3 (PI044003), 2017 SGR 1717 from Generalitat de Catalunya, a CICYTgrant provided by the Ministerio de Ciencia, Innovación y Universidades(AGL2016-75329-R), and funds from the European Regional Develop ment Fund (CB06/03 and CB12/03).
DS RISalud
RD Apr 4, 2025